Open access peer-reviewed chapter

Application of Computer Modeling to Drug Discovery: Case Study of PRK1 Kinase Inhibitors as Potential Drugs in Prostate Cancer Treatment

By Abdulkarim Najjar, Fidele Ntie-Kang and Wolfgang Sippl

Submitted: November 6th 2016Reviewed: March 31st 2017Published: July 12th 2017

DOI: 10.5772/intechopen.68910

Downloaded: 353

© 2017 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Abdulkarim Najjar, Fidele Ntie-Kang and Wolfgang Sippl (July 12th 2017). Application of Computer Modeling to Drug Discovery: Case Study of PRK1 Kinase Inhibitors as Potential Drugs in Prostate Cancer Treatment, Unique Aspects of Anti-cancer Drug Development Jolanta Natalia Latosińska, IntechOpen, DOI: 10.5772/intechopen.68910. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/unique-aspects-of-anti-cancer-drug-development/application-of-computer-modeling-to-drug-discovery-case-study-of-prk1-kinase-inhibitors-as-potential" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

353total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Annexin Proteins: Novel Promising Targets for Anticancer Drug Development

By Filiz Bakar

Related Book

First chapter

Introductory Chapter: Caffeine, a Major Component of Nectar of the Gods and Favourite Beverage of Kings, Popes, Artists and Revolutionists, a Drug or a Poison?

By Magdalena Latosińska and Jolanta Natalia Latosińska

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us